SCHEMBL24675836

SCHEMBL24675836

COC(=O)CCCCCOCCOCCOCCCCCCOc1ccc(F)c(C(C)N)c1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 6/20 0.43
▸ PDE3A Q14432 6/20 0.43
▸ P2RY12 Q9H244 5/20 0.43
▸ PPARG P37231 2/20 0.41
▸ PPARA Q07869 1/20 0.41
▸ CNR2 P34972 3/20 0.40
▸ PDE2A O00408 2/20 0.40
▸ RARA P10276 1/20 0.38
▸ RARB P10826 1/20 0.38
▸ FFAR1 O14842 1/20 0.38
▸ FFAR4 Q5NUL3 1/20 0.38
▸ MAPT P10636 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.36
▸ LTB4R Q15722 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ ITGB3 P05106 1/20 0.36
▸ ITGA2B P08514 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24675839 1.00 PDE3B (0.43) PDE3BPDE3AP2RY12PPARGPPARA
SCHEMBL24675515 1.00 PDE3B (0.43) PDE3BPDE3AP2RY12PPARGPPARA
Hydrochloric Acid SCHEMBL29822777 0.99 PDE3B (0.42) PDE3BPDE3AP2RY12PPARGPPARA
SCHEMBL29822868 0.82 PDE3B (0.38) PDE3BPDE3AP2RY12PPARGPPARA
SCHEMBL29823042 0.82 PDE3B (0.38) PDE3BPDE3AP2RY12PPARGPPARA
SCHEMBL24675802 0.82 PDE3B (0.38) PDE3BPDE3AP2RY12PPARGPPARA
SCHEMBL24675790 0.82 PDE3B (0.38) PDE3BPDE3AP2RY12PPARGPPARA
SCHEMBL24675148 0.82 PDE3B (0.44) PDE3BPDE3AP2RY12CNR2PDE2A
Hydrochloric Acid SCHEMBL25245928 0.81 PDE3B (0.43) PDE3BPDE3AP2RY12CNR2PDE2A
SCHEMBL25824077 0.81 PDE3B (0.41) PDE3BPDE3AP2RY12PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022159688-A9 DEGRADERS OF GRK2 AND USES THEREOF SONATA THERAPEUTICS, INC. (US) 2023-09-21 — — WO disclosed
WO-2022159688-A1 DEGRADERS OF GRK2 AND USES THEREOF CYGNAL THERAPEUTICS, INC. (US) 2022-07-28 — — WO disclosed
Send feedback